Observational, retrospective, real‐world omalizumab in patients with chronic spontaneous urticaria
Latest Information Update: 01 Jan 2021
At a glance
- Drugs Omalizumab (Primary)
- Indications Urticaria
- Focus Adverse reactions; Therapeutic Use
- 01 Jan 2021 New trial record